This strategy was applied for targeted delivery of Docetaxel to cancer cell using an optimized formulation of anti-HER2 mAb decorated PLGA-PEG NPs where the free amine group of PEG was covalently attached to the carboxylic group of antibody [57]. The gene discussed is ERBB2; the disease is cancer.